SNDX - Syndax Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SNDX is currently covered by 7 analysts with an average price target of $42.86. This is a potential upside of $19.3 (143.25%) from yesterday's end of day stock price of $17.62.

Syndax Pharmaceuticals's activity chart (see below) currently has 160 price targets and 117 ratings on display. The stock rating distribution of SNDX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.44% with an average time for these price targets to be met of 177.53 days.

Highest price target for SNDX is $57, Lowest price target is $33, average price target is $42.86.

Most recent stock forecast was given by DAVID DAI from UBS on 21-Aug-2026. First documented stock forecast 31-Mar-2016.

Currently out of the existing stock ratings of SNDX, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Oct-2024

$33

$15.38 (87.29%)

$38

1 months ago
(21-Aug-2026)

0/4 (0%)

$13.35 (67.94%)

Buy Since 03-Jan-2023

$40

$22.38 (127.01%)

$45

1 months 10 days ago
(11-Aug-2026)

0/14 (0%)

$19.71 (97.14%)

Corinne Johnson

Buy Since 10-Jul-2025

$34

$12.69 (59.55%)

$24

5 months 20 days ago
(01-Apr-2026)

3/4 (75%)

$10.12 (42.38%)

149

Buy Since 25-May-2021

$57

$35.69 (167.48%)

$51

6 months 19 days ago
(02-Mar-2026)

3/12 (25%)

$34.86 (157.45%)

355

Buy Since 04-Mar-2020

$35

$13.69 (64.24%)

$22

9 months 28 days ago
(24-Nov-2025)

3/8 (37.5%)

$15.24 (77.13%)

101

Show more analysts

Please expand the browser size to see the chart

What is SNDX (Syndax Pharmaceuticals) average time for price targets to be met?

On average it took 178 days for the stock forecasts to be reached, with an average price target met ratio of 23.44%.

Which analyst most recently updated their price target on SNDX (Syndax Pharmaceuticals)?

David Dai

Which analyst has the most public recommendations on SNDX (Syndax Pharmaceuticals)?

David Dai works at UBS and has 3 price targets and 2 ratings on SNDX

Which analyst is the currently most bullish on SNDX (Syndax Pharmaceuticals)?

Yigal Nochomovitz with the highest potential upside of $39.38

Which analyst is the currently most reserved on SNDX (Syndax Pharmaceuticals)?

George Farmer with the lowest potential downside of -$4.31

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?